ID   HIBCH_HUMAN             Reviewed;         386 AA.
AC   Q6NVY1; D3DPI4; Q53GA8; Q53GF2; Q53RF7; Q53TC6; Q92931; Q9BS94;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   10-MAY-2017, entry version 120.
DE   RecName: Full=3-hydroxyisobutyryl-CoA hydrolase, mitochondrial;
DE            EC=3.1.2.4;
DE   AltName: Full=3-hydroxyisobutyryl-coenzyme A hydrolase;
DE            Short=HIB-CoA hydrolase;
DE            Short=HIBYL-CoA-H;
DE   Flags: Precursor;
GN   Name=HIBCH;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=8824301; DOI=10.1074/jbc.271.42.26430;
RA   Hawes J.W., Jaskiewicz J., Shimomura Y., Huang B., Bunting J.,
RA   Harper E.T., Harris R.A.;
RT   "Primary structure and tissue-specific expression of human beta-
RT   hydroxyisobutyryl-coenzyme A hydrolase.";
RL   J. Biol. Chem. 271:26430-26434(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-46.
RC   TISSUE=Small intestine;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT ALA-46.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ALA-46.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-92, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-234 AND SER-356, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 32-386 IN COMPLEX WITH
RP   3-HYDROXY-2-METHYLPROPANOIC ACID AND QUERCETIN.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human beta-hydroxyisobutyryl-COA hydrolase in
RT   complex with quercetin.";
RL   Submitted (JAN-2008) to the PDB data bank.
RN   [12]
RP   VARIANT HIBCHD CYS-122.
RX   PubMed=17160907; DOI=10.1086/510725;
RA   Loupatty F.J., Clayton P.T., Ruiter J.P.N., Ofman R., Ijlst L.,
RA   Brown G.K., Thorburn D.R., Harris R.A., Duran M., Desousa C.,
RA   Krywawych S., Heales S.J.R., Wanders R.J.A.;
RT   "Mutations in the gene encoding 3-hydroxyisobutyryl-CoA hydrolase
RT   results in progressive infantile neurodegeneration.";
RL   Am. J. Hum. Genet. 80:195-199(2007).
CC   -!- FUNCTION: Hydrolyzes 3-hydroxyisobutyryl-CoA (HIBYL-CoA), a saline
CC       catabolite. Has high activity toward isobutyryl-CoA. Could be an
CC       isobutyryl-CoA dehydrogenase that functions in valine catabolism.
CC       Also hydrolyzes 3-hydroxypropanoyl-CoA.
CC       {ECO:0000269|PubMed:8824301}.
CC   -!- CATALYTIC ACTIVITY: 3-hydroxy-2-methylpropanoyl-CoA + H(2)O = CoA
CC       + 3-hydroxy-2-methylpropanoate. {ECO:0000269|PubMed:8824301}.
CC   -!- PATHWAY: Amino-acid degradation; L-valine degradation.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6NVY1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6NVY1-2; Sequence=VSP_024780;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver and kidney, also
CC       detected in heart, muscle and brain (at protein level). Not
CC       detected in lung. {ECO:0000269|PubMed:8824301}.
CC   -!- DISEASE: 3-hydroxyisobutryl-CoA hydrolase deficiency (HIBCHD)
CC       [MIM:250620]: An autosomal recessive inborn error of valine
CC       metabolism. It causes severely delayed psychomotor development,
CC       neurodegeneration, increased lactic acid, and brain lesions in the
CC       basal ganglia. {ECO:0000269|PubMed:17160907}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the enoyl-CoA hydratase/isomerase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC52114.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAH05190.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=AAY24178.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAD96699.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAD96743.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U66669; AAC52114.1; ALT_INIT; mRNA.
DR   EMBL; AK222979; BAD96699.1; ALT_INIT; mRNA.
DR   EMBL; AK223023; BAD96743.1; ALT_INIT; mRNA.
DR   EMBL; AC092178; AAY24178.1; ALT_INIT; Genomic_DNA.
DR   EMBL; AC010679; AAX93234.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10873.1; -; Genomic_DNA.
DR   EMBL; CH471058; EAX10875.1; -; Genomic_DNA.
DR   EMBL; BC005190; AAH05190.2; ALT_INIT; mRNA.
DR   EMBL; BC067822; AAH67822.1; -; mRNA.
DR   CCDS; CCDS2304.1; -. [Q6NVY1-1]
DR   CCDS; CCDS46475.1; -. [Q6NVY1-2]
DR   RefSeq; NP_055177.2; NM_014362.3. [Q6NVY1-1]
DR   RefSeq; NP_932164.1; NM_198047.2. [Q6NVY1-2]
DR   RefSeq; XP_011509255.1; XM_011510953.1. [Q6NVY1-1]
DR   UniGene; Hs.656685; -.
DR   PDB; 3BPT; X-ray; 1.50 A; A=32-386.
DR   PDBsum; 3BPT; -.
DR   ProteinModelPortal; Q6NVY1; -.
DR   SMR; Q6NVY1; -.
DR   BioGrid; 117658; 35.
DR   IntAct; Q6NVY1; 2.
DR   STRING; 9606.ENSP00000352706; -.
DR   DrugBank; DB04216; Quercetin.
DR   iPTMnet; Q6NVY1; -.
DR   PhosphoSitePlus; Q6NVY1; -.
DR   BioMuta; HIBCH; -.
DR   DMDM; 146324905; -.
DR   REPRODUCTION-2DPAGE; IPI00419802; -.
DR   EPD; Q6NVY1; -.
DR   MaxQB; Q6NVY1; -.
DR   PaxDb; Q6NVY1; -.
DR   PeptideAtlas; Q6NVY1; -.
DR   PRIDE; Q6NVY1; -.
DR   Ensembl; ENST00000359678; ENSP00000352706; ENSG00000198130. [Q6NVY1-1]
DR   Ensembl; ENST00000392332; ENSP00000376144; ENSG00000198130. [Q6NVY1-2]
DR   GeneID; 26275; -.
DR   KEGG; hsa:26275; -.
DR   UCSC; uc002uru.3; human. [Q6NVY1-1]
DR   CTD; 26275; -.
DR   DisGeNET; 26275; -.
DR   GeneCards; HIBCH; -.
DR   HGNC; HGNC:4908; HIBCH.
DR   HPA; HPA036540; -.
DR   HPA; HPA036541; -.
DR   MalaCards; HIBCH; -.
DR   MIM; 250620; phenotype.
DR   MIM; 610690; gene.
DR   neXtProt; NX_Q6NVY1; -.
DR   OpenTargets; ENSG00000198130; -.
DR   Orphanet; 88639; Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency.
DR   PharmGKB; PA29281; -.
DR   eggNOG; KOG1684; Eukaryota.
DR   eggNOG; COG1024; LUCA.
DR   GeneTree; ENSGT00570000079226; -.
DR   HOVERGEN; HBG054809; -.
DR   InParanoid; Q6NVY1; -.
DR   KO; K05605; -.
DR   OrthoDB; EOG091G07GX; -.
DR   PhylomeDB; Q6NVY1; -.
DR   TreeFam; TF314329; -.
DR   BRENDA; 3.1.2.4; 2681.
DR   Reactome; R-HSA-70895; Branched-chain amino acid catabolism.
DR   SABIO-RK; Q6NVY1; -.
DR   UniPathway; UPA00362; -.
DR   EvolutionaryTrace; Q6NVY1; -.
DR   GenomeRNAi; 26275; -.
DR   PRO; PR:Q6NVY1; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000198130; -.
DR   CleanEx; HS_HIBCH; -.
DR   ExpressionAtlas; Q6NVY1; baseline and differential.
DR   Genevisible; Q6NVY1; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0003860; F:3-hydroxyisobutyryl-CoA hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0009083; P:branched-chain amino acid catabolic process; TAS:Reactome.
DR   GO; GO:0006574; P:valine catabolic process; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR029045; ClpP/crotonase-like_dom.
DR   InterPro; IPR032259; HIBYL-CoA-H.
DR   Pfam; PF16113; ECH_2; 1.
DR   SUPFAM; SSF52096; SSF52096; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing;
KW   Branched-chain amino acid catabolism; Complete proteome;
KW   Disease mutation; Hydrolase; Mitochondrion; Phosphoprotein;
KW   Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     32       Mitochondrion. {ECO:0000250}.
FT   CHAIN        33    386       3-hydroxyisobutyryl-CoA hydrolase,
FT                                mitochondrial.
FT                                /FTId=PRO_0000284929.
FT   BINDING     121    121       Substrate.
FT   BINDING     146    146       Substrate; via amide nitrogen.
FT   BINDING     169    169       Substrate.
FT   BINDING     177    177       Substrate.
FT   MOD_RES      55     55       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES      55     55       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES      92     92       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES      92     92       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     221    221       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     221    221       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     234    234       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     257    257       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     297    297       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     297    297       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     301    301       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     353    353       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     353    353       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     360    360       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     365    365       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   MOD_RES     377    377       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8QZS1}.
FT   VAR_SEQ     338    385       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_024780.
FT   VARIANT      46     46       T -> A (in dbSNP:rs1058180).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.2, ECO:0000269|Ref.4}.
FT                                /FTId=VAR_031869.
FT   VARIANT     122    122       Y -> C (in HIBCHD; dbSNP:rs121918329).
FT                                {ECO:0000269|PubMed:17160907}.
FT                                /FTId=VAR_031870.
FT   CONFLICT     41     41       E -> G (in Ref. 5; AAH67822).
FT                                {ECO:0000305}.
FT   CONFLICT     83     83       L -> V (in Ref. 1; AAC52114).
FT                                {ECO:0000305}.
FT   CONFLICT    111    111       Q -> R (in Ref. 2; BAD96699).
FT                                {ECO:0000305}.
FT   CONFLICT    184    198       LPRLQGKLGYFLALT -> FATTPRKTWLLPCIN (in
FT                                Ref. 1; AAC52114). {ECO:0000305}.
FT   CONFLICT    369    369       E -> K (in Ref. 2; BAD96699).
FT                                {ECO:0000305}.
FT   STRAND       37     43       {ECO:0000244|PDB:3BPT}.
FT   STRAND       46     51       {ECO:0000244|PDB:3BPT}.
FT   HELIX        54     56       {ECO:0000244|PDB:3BPT}.
FT   HELIX        62     77       {ECO:0000244|PDB:3BPT}.
FT   STRAND       83     88       {ECO:0000244|PDB:3BPT}.
FT   STRAND       91     95       {ECO:0000244|PDB:3BPT}.
FT   HELIX       100    107       {ECO:0000244|PDB:3BPT}.
FT   HELIX       114    129       {ECO:0000244|PDB:3BPT}.
FT   STRAND      135    139       {ECO:0000244|PDB:3BPT}.
FT   STRAND      141    144       {ECO:0000244|PDB:3BPT}.
FT   HELIX       146    149       {ECO:0000244|PDB:3BPT}.
FT   TURN        150    153       {ECO:0000244|PDB:3BPT}.
FT   STRAND      154    159       {ECO:0000244|PDB:3BPT}.
FT   STRAND      164    166       {ECO:0000244|PDB:3BPT}.
FT   HELIX       169    171       {ECO:0000244|PDB:3BPT}.
FT   HELIX       180    186       {ECO:0000244|PDB:3BPT}.
FT   HELIX       191    198       {ECO:0000244|PDB:3BPT}.
FT   HELIX       205    209       {ECO:0000244|PDB:3BPT}.
FT   STRAND      214    216       {ECO:0000244|PDB:3BPT}.
FT   HELIX       219    221       {ECO:0000244|PDB:3BPT}.
FT   HELIX       222    231       {ECO:0000244|PDB:3BPT}.
FT   HELIX       237    250       {ECO:0000244|PDB:3BPT}.
FT   TURN        253    256       {ECO:0000244|PDB:3BPT}.
FT   HELIX       262    264       {ECO:0000244|PDB:3BPT}.
FT   HELIX       265    271       {ECO:0000244|PDB:3BPT}.
FT   STRAND      274    276       {ECO:0000244|PDB:3BPT}.
FT   HELIX       277    287       {ECO:0000244|PDB:3BPT}.
FT   HELIX       290    299       {ECO:0000244|PDB:3BPT}.
FT   HELIX       304    317       {ECO:0000244|PDB:3BPT}.
FT   HELIX       322    337       {ECO:0000244|PDB:3BPT}.
FT   HELIX       341    349       {ECO:0000244|PDB:3BPT}.
FT   HELIX       364    366       {ECO:0000244|PDB:3BPT}.
FT   HELIX       369    376       {ECO:0000244|PDB:3BPT}.
FT   HELIX       380    382       {ECO:0000244|PDB:3BPT}.
SQ   SEQUENCE   386 AA;  43482 MW;  11B0632ED1DF2FFA CRC64;
     MGQREMWRLM SRFNAFKRTN TILHHLRMSK HTDAAEEVLL EKKGCTGVIT LNRPKFLNAL
     TLNMIRQIYP QLKKWEQDPE TFLIIIKGAG GKAFCAGGDI RVISEAEKAK QKIAPVFFRE
     EYMLNNAVGS CQKPYVALIH GITMGGGVGL SVHGQFRVAT EKCLFAMPET AIGLFPDVGG
     GYFLPRLQGK LGYFLALTGF RLKGRDVYRA GIATHFVDSE KLAMLEEDLL ALKSPSKENI
     ASVLENYHTE SKIDRDKSFI LEEHMDKINS CFSANTVEEI IENLQQDGSS FALEQLKVIN
     KMSPTSLKIT LRQLMEGSSK TLQEVLTMEY RLSQACMRGH DFHEGVRAVL IDKDQSPKWK
     PADLKEVTEE DLNNHFKSLG SSDLKF
//
